Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LifeTech Scientific Corporation ( (HK:1302) ) has shared an update.
LifeTech Scientific Corporation announced the resignation of independent non-executive director Wang Wansong, who is stepping down effective 26 January 2026 after serving more than nine years, in order to comply with Hong Kong Stock Exchange requirements on long-serving independent directors. His departure leaves the company temporarily below the minimum number of independent non-executive directors and committee members required under the Listing Rules, prompting the board to commit to appointing a suitable replacement within three months, while simultaneously naming existing independent director Chen Dongxia as chair of the remuneration committee to ensure continuity in key board functions.
The most recent analyst rating on (HK:1302) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on LifeTech Scientific Corporation stock, see the HK:1302 Stock Forecast page.
More about LifeTech Scientific Corporation
LifeTech Scientific Corporation is a Hong Kong-listed company incorporated in the Cayman Islands, operating through a group structure with subsidiaries. The company is governed by a board comprising executive, non-executive and independent non-executive directors and is subject to the corporate governance and listing requirements of the Hong Kong Stock Exchange.
Average Trading Volume: 32,494,192
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.77B
For a thorough assessment of 1302 stock, go to TipRanks’ Stock Analysis page.